April 16, 2026 01:20 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘We are surprised’: SC stays Pawan Khera’s bail over remarks on Himanta Biswa Sarma’s wife | Historic shift: Bihar gets first BJP CM as Samrat Choudhary takes oath | 'ECI deviated from Bihar procedure': Supreme Court raises concerns over voter deletion in Bengal SIR | Noida workers’ protest turns violent: Stones pelted, vehicles damaged over wage hike demand | Oil prices jump above $103 a barrel as US moves to block Iran-linked shipping | I don’t care if they come back or not, says Trump after Iran talks collapse | Legendary singer Asha Bhosle suffers cardiac arrest, hospitalised | Big boost to India–Mauritius ties: S. Jaishankar hands over 90 e-buses | Middle East tension: Iranian delegation arrives in Islamabad for major talks, 10,000 security personnel deployed | Ranveer Singh visits RSS HQ amid Dhurandhar 2 success, triggers speculation
Covid Vaccine
Image Credit: Pixabay

Pfizer- BioNTech seek permission for emergency use of Covid-19 vaccine in adolescents in US

| @indiablooms | Apr 10, 2021, at 06:11 am

Washington/IBNS: US drug major Pfizer Inc and its German partner BioNTech SE have sought the permission for emergency use of their vaccine in adolescents aged 12 to 15, according to a Reuters report.

Pfizer Inc and BioNTech stated that they have made a request to the US Food and Drug Administration for the expansion of use of their vaccine which proved to be 90 per cent effective against the novel coronavirus in clinical trials.

In March, the drugmakers said that their vaccine has shown positive results and proven safe among the age group 12 to 15 in a clinical trial.

This could be a big development as drugmakers across the world are still facing the question if the vaccine works and is safe for use in children.

Inoculating children is a major step toward achieving "herd immunity" and controlling the pandemic, according to experts, the report said.

The companies plan to approach other regulatory authorities across the globe for similar permissions.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.